RNAC
Cartesian Therapeutics, Inc.
$7.01-0.08 (-1.13%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Cartesian Therapeutics, Inc. (RNAC) is a publicly traded company with 3 insider transactions disclosed via SEC Form 4 in the past 90 days, involving 3 unique insiders. All data below is sourced directly from public SEC EDGAR Form 4 filings.
Latest Insider Transactions
Showing 10 of 41 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-06 | 2026-04-02 | Hoge Elizabeth | 10% Owner | Exercise Conversion | 758,001 | $0.00 | $0 | N/A | N/A |
| 2026-04-06 | 2026-04-02 | Kalayoglu Murat | 10% Owner | Exercise Conversion | 758,001 | $0.00 | $0 | N/A | N/A |
| 2026-03-13 | 2026-03-13 | Singer Michael | Director | Gift | 6,555 | $0.00 | $0 | N/A | N/A |
| 2026-01-08 | 2026-01-06 | Miljkovic Milos | CMO | Sale | 3,573 | $6.82 | -$24,368 | N/A | N/A |
| 2026-01-08 | 2026-01-06 | Brunn Carsten | CEO | Sale | 23,766 | $6.82 | -$162,084 | N/A | N/A |
| 2026-01-08 | 2026-01-06 | Davis Blaine | CFO | Sale | 10,591 | $6.82 | -$72,231 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Davis Blaine | CFO | Award | 37,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Zenner Patrick J | Director | Award | 7,800 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Springer Timothy A | Director | Award | 7,800 | $0.00 | $0 | N/A | N/A |
| 2026-01-06 | 2026-01-02 | Desilva Nishan M | Director | Award | 7,800 | $0.00 | $0 | N/A | N/A |
RNAC
10% Owner
Exercise Conversion
$0
Hoge Elizabeth758,001 shares @ $0.00
Filed 2026-04-06Trade 2026-04-02
RNAC
10% Owner
Exercise Conversion
$0
Kalayoglu Murat758,001 shares @ $0.00
Filed 2026-04-06Trade 2026-04-02
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.